Skip to content

Salvia divinorum: all studies

Page 10 of 41: studies 91 to 100 of 407, newest first. Back to the salvia divinorum overview

Research

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.

Frontiers in Pharmacology 2015 Eduardo R Butelman, Mary Jeanne Kreek 3 citations correction

In the original review, we placed an incorrect citation in a sentence. The correct sentence and citation are as follows: "Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting MOPr agonist in primates (when given contingently; Freeman et al., 2014).” The authors apologize for the mistake. This error does not change the scientific conclusions of the...

Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.

Journal of Medicinal Chemistry December 26, 2014 Andrew P Riley, Chad E Groer, David Young et al. 115 citations

The neoclerodane diterpene salvinorin A, found in the leaves of Salvia divinorum, is a potent κ-opioid receptor agonist, making it an attractive scaffold for development into a treatment for substance abuse. Although several successful semisynthetic studies have been performed to elucidate structure-activity relationships, the lack of analogues with substitutions to the furan ring of salvinorin...

Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.

Neuropharmacology November 1, 2014 Bronwyn M Kivell, Zeljko Uzelac, Santhanalakshmi Sundaramurthy et al.

Salvinorin A (SalA), a selective κ-opioid receptor (KOR) agonist, produces dysphoria and pro-depressant like effects. These actions have been attributed to inhibition of striatal dopamine release. The dopamine transporter (DAT) regulates dopamine transmission via uptake of released neurotransmitter. KORs are apposed to DAT in dopamine nerve terminals suggesting an additional target by which...

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.

European journal of medicinal chemistry October 6, 2014 Prabhakar R Polepally, Krzysztof Huben, Eyal Vardy et al. 28 citations

The neoclerodane diterpenoid salvinorin A is a major secondary metabolite isolated from the psychoactive plant Salvia divinorum. Salvinorin A has been shown to have high affinity and selectivity for the κ-opioid receptor (KOR). To study the ligand-receptor interactions that occur between salvinorin A and the KOR, a new series of salvinorin A derivatives bearing potentially reactive Michael...

Analysis of the smoke of cigarettes containing Salvia divinorum.

Journal of Analytical Toxicology September 1, 2014 John L Krstenansky, Miguel Muzzio

Salvia divinorum is a hallucinogen sold over the internet in several forms. Perhaps the most common method of use is smoking the dried leaf material. The sole presumed active constituent, salvinorin A, is a selective kappa-opioid receptor agonist. Upon smoking of the dried leaf material, some of the salvinorin A is destroyed or converted to other materials, leaving in question the actual amount...

Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet.

Forensic Science International September 1, 2014 Fernando Xavier Moreira, Félix Carvalho, Maria de Lourdes Bastos et al. 13 citations

Lately, the hallucinogenic plant Salvia divinorum has been considered a popular recreational product among adolescents, being legally sold in several countries in "smartshops" and in internet websites. Sellers frequently omit the safety information about the plant, encouraging its use for recreational purposes, without providing adequate qualitative and quantitative details. The principal...

Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys.

Psychopharmacology July 1, 2014 Kevin B Freeman, Jennifer E Naylor, Thomas E Prisinzano et al.

Drugs can function as punishers. However, work on the study of drugs as punishers is limited, as is the range of compounds known to function as punishers. Kappa opioid agonists, which have received much experimental attention as potential therapeutics for drug abuse, reportedly produce aversive effects. However, kappa agonists have yet to be tested as punishers of behavior. The goal of the...

From local to global-fifty years of research on Salvia divinorum.

Journal of Ethnopharmacology February 3, 2014 Ivan Casselman, Catherine J Nock, Hans Wohlmuth et al. 54 citations

In 1962 ethnopharmacologists, Hofmann and Wasson, undertook an expedition to Oaxaca, Mexico. These two researchers were the first scientists to collect a flowering specimen of Salvia divinorum allowing the identification of this species. While the species' traditional use is confined to a very small region of Mexico, since Hofmann and Wasson's expedition 50 years ago, Salvia divinorum has...

DOI: 10.1016/j.jep.2013.11.032 (opens in new tab) Full text (opens in new tab) 2.136: botany 2.232: diterpenoids 2.312: hallucinogenic Psychoactive diterpene +4

Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans.

Translational Perioperative and Pain Medicine 2014 Edward Orton, Renyu Liu

Salvinorin A is a potent and selective agonist of kappa opioid receptors in the brain. Recent studies in several animal models have revealed that Salvinorin A has anti-addiction, anti-depression properties and exhibits pronounced neuroprotective effects against hypoxia/ischemia induced brain damage, and have raised interest in potential clinical applications in several acute pathologies...

The effect of Salvia divinorum and Mitragyna speciosa extracts, fraction and major constituents on place aversion and place preference in rats.

Journal of Ethnopharmacology 2014 Kenneth J. Sufka, Melissa J Loria, Kevin Lewellyn et al.

Consumer use of botanicals has increased despite, in many instances, the paucity of research demonstrating efficacy or identifying liabilities. This research employed the place preference/aversion paradigm to characterize the psychoactive properties of Salvia divinorum extract (10, 30, 100mg/kg), salvinorin A (0.1, 0.3, 1.0mg/kg), Mitragyna speciosa MeOH extract (50, 100, 300 mg/kg), Mitragyna...